ArticleJournal of ovarian research2026
Cumulative live birth after unstimulated in vitro maturation versus conventional in vitro fertilization (IVF) in women with polycystic ovary syndrome: a 36-month retrospective matched cohort study.
Article in Journal of ovarian research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundPolycystic ovary syndrome (PCOS) is characterized by heterogeneous ovarian responsiveness and a heightened risk of ovarian hyperstimulation syndrome (OHSS) during gonadotropin stimulation. Strictly unstimulated in vitro maturation (IVM) avoids ovarian stimulation and may reduce treatment burden; however, long-term cumulative live birth outcomes remain insufficiently defined, especially across baseline ovarian phenotypes.
methodsThis retrospective matched cohort study included women aged 20–42 years with PCOS, diagnosed by the Rotterdam criteria, treated at a university-affiliated fertility center between January 2010 and December 2022 (follow-up through December 2023). Women undergoing unstimulated IVM (n = 545) were matched 1:3 by age and BMI to women undergoing conventional in vitro fertilization (IVF) using a GnRH antagonist protocol (n = 1,635). The primary outcome was the 36-month cumulative live birth rate (CLBR) per initiated oocyte retrieval cycle. Secondary outcomes included implantation and live birth after the first transfer (fresh vs. frozen), OHSS, and obstetric/perinatal outcomes. Odds ratios (ORs) were calculated for the freeze-all subset.
resultsThe 36-month CLBR per initiated retrieval cycle was significantly lower with IVM than IVF (22.20% vs. 47.95%; P < 0.001). CLBR/embryo transfer cycles was also lower with IVM (31.43% vs. 50.19%; P < 0.001). Implantation was lower in the IVM group after fresh transfer (22.94% vs. 29.45%; P = 0.005) but higher after frozen embryo transfer (43.86% vs. 32.62%; P = 0.007). Live birth after the first fresh transfer was lower with IVM (25.96% vs. 33.20%; P = 0.029), whereas after the first frozen transfer, live birth was comparable (33.33% vs. 36.61%; P = 0.486). No severe OHSS occurred in the IVM group, compared to 0.98% in IVF cycles. In women with AFC ≥ 24, live birth after the first frozen transfer was similar between groups (OR 0.99, 95% CI 0.57–1.72). Obstetric and neonatal outcomes were broadly comparable.
conclusionsUnstimulated IVM in PCOS women yielded a lower 36-month CLBR compared to IVF, primarily due to lower embryo yield. IVM eliminated OHSS and achieved comparable live birth rates following the FET, particularly in women with high AFC. These findings advocate for a ‘freeze-all’ IVM strategy to optimize both safety and reproductive outcomes in this high-risk population. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.